Physician

Christopher John Douglas, M.D.

According to 2025 Medicare claims, Christopher Douglas, M.D. (NPI: 1427251511) practices interventional cardiology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is HATTIESBURG CLINIC PA (NPI: 1740213446; TIN: 640507572) and primary practice location at 39401-7246. Douglas is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Douglas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 4,566 traditional Medicare patients, billed 21,047 HCPCS/CPT codes, and received $1,818,547 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,761 prescription claims across 1,416 beneficiaries totaling $1,560,165 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 26 records totaling $435. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $125,962 to $1,818,547. Similarly, Part D prescription costs have moved sharply higher in recent years, from $12,285 to $1,560,165. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	391	1,118	$125,962
2016	912	3,913	$353,043
2017	1,006	4,145	$387,896
2018	1,703	7,355	$731,008
2019	1,946	10,127	$970,470
2020	1,966	8,938	$1,156,006
2021	2,275	9,502	$1,182,596
2022	3,264	14,578	$1,491,147
2023	4,150	19,808	$1,777,255
2024	4,566	21,047	$1,818,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	232	$12,285
2016	254	2,081	$112,997
2017	319	2,958	$165,532
2018	453	3,329	$203,820
2019	596	3,845	$363,978
2020	725	4,635	$553,716
2021	876	5,250	$733,430
2022	999	6,130	$872,605
2023	1,232	7,315	$1,221,418
2024	1,416	8,761	$1,560,165

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,313	1,342	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,236	1,375	$82
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,474	1,640	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,703	2,025	$6
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	1,448	1,892	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	682	31,233	$612,017
Jardiance	Empagliflozin	284	11,574	$218,044
Xarelto	Rivaroxaban	213	10,567	$206,212
Entresto	Sacubitril/Valsartan	139	7,095	$152,104
Brilinta	Ticagrelor	236	8,760	$124,364

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$435	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher John Douglas, M.D.?

Tedicare shows public-source Medicare data for Christopher John Douglas, M.D. (NPI 1427251511), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher John Douglas, M.D. have ACO affiliation data?

Christopher John Douglas, M.D. is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to Christopher John Douglas, M.D.?

Christopher John Douglas, M.D. is linked to HATTIESBURG CLINIC PA (billing NPI 1740213446) in the available physician profile data.

Does Christopher John Douglas, M.D. have Open Payments data?

Christopher John Douglas, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.